Shibata Yoko, Inoue Sumito, Igarashi Akira, Yamauchi Keiko, Abe Shuichi, Aida Yasuko, Nunomiya Keiko, Sato Masamichi, Nakano Hiroshi, Sato Kento, Nemoto Takako, Kimura Tomomi, Watanabe Tetsu, Konta Tsuneo, Daimon Makoto, Ueno Yoshiyuki, Kato Takeo, Kayama Takamasa, Kubota Isao
Department of Cardiology, Pulmonology and Nephrology, School of Medicine, Yamagata University, Yamagata City, Yamagata, Japan.
Global Center of Excellence Program Study Group, School of Medicine, Yamagata University, Yamagata City, Yamagata, Japan.
PLoS One. 2013 Dec 13;8(12):e83725. doi: 10.1371/journal.pone.0083725. eCollection 2013.
Chronic obstructive pulmonary disease is a known risk factor for cardiovascular death in Western countries. Because Japan has a low cardiovascular death rate, the association between a lower level of forced expiratory volume in 1 s (FEV1) and mortality in Japan's general population is unknown. To clarify this, we conducted a community-based longitudinal study. This study included 3253 subjects, who received spirometry from 2004 to 2006 in Takahata, with a 7-year follow-up. The causes of death were assessed on the basis of the death certificate. In 338 subjects, airflow obstruction was observed by spirometry. A total of 127 subjects died. Cardiovascular death was the second highest cause of death in this population. The pulmonary functions of the deceased subjects were significantly lower than those of the subjects who were alive at the end of follow-up. The relative risk of death by all causes, respiratory failure, lung cancer, and cardiovascular disease was significantly increased with airflow obstruction. The Kaplan-Meier analysis showed that all-cause and cardiovascular mortality significantly increased with a worsening severity of airflow obstruction. After adjusting for possible factors that could influence prognosis, a Cox proportional hazard model analysis revealed that a lower level of FEV1 was an independent risk factor for all-cause and cardiovascular mortality (per 10% increase; hazard ratio [HR], 0.89; 95% confidence interval [CI], 0.82-0.98; and HR, 0.72; 95% CI, 0.61-0.86, respectively). In conclusion, airflow obstruction is an independent risk factor for all-cause and cardiovascular death in the Japanese general population. Spirometry might be a useful test to evaluate the risk of cardiovascular death and detect the risk of respiratory death by lung cancer or respiratory failure in healthy Japanese individuals.
在西方国家,慢性阻塞性肺疾病是心血管死亡的已知危险因素。由于日本的心血管死亡率较低,一秒用力呼气量(FEV1)水平较低与日本普通人群死亡率之间的关联尚不清楚。为了阐明这一点,我们进行了一项基于社区的纵向研究。该研究纳入了3253名受试者,他们于2004年至2006年在高幡接受了肺活量测定,并进行了7年的随访。根据死亡证明评估死亡原因。通过肺活量测定观察到338名受试者存在气流受限。共有127名受试者死亡。心血管死亡是该人群中第二大死亡原因。死亡受试者的肺功能显著低于随访结束时存活的受试者。气流受限使全因死亡、呼吸衰竭、肺癌和心血管疾病的相对死亡风险显著增加。Kaplan-Meier分析表明,全因死亡率和心血管死亡率随气流受限严重程度的加重而显著增加。在对可能影响预后的因素进行校正后,Cox比例风险模型分析显示,较低的FEV1水平是全因死亡率和心血管死亡率的独立危险因素(每增加10%;风险比[HR],0.89;95%置信区间[CI],0.82-0.98;以及HR,0.72;95%CI,0.61-0.86)。总之,气流受限是日本普通人群全因死亡和心血管死亡的独立危险因素。肺活量测定可能是评估日本健康个体心血管死亡风险以及检测肺癌或呼吸衰竭导致的呼吸死亡风险的有用检查。